Transgenic Animals Market Research Report by Products (Gene Gun, Microinjection), Techniques (DNA Microinjection), Consumables (Probes), Application (Monoclonal Abs), Transgenic Animals (Mice) End User (Biotech Industries) - Forecast till 2030

Transgenic Animals Market Overview

Transgenic animals always carry a foreign gene that is inserted into their genome. A new recombinant DNA technology is being used where foreign DNA is inserted into the host body. The foreign gene is facilitated easily through the germline so that each of the animals has some of the modified genetic material. In 1997, the first transgenic cow named Rosie was produced and was considered the human enriched proteinaceous milk cow. The milk produced was nutrient-rich as compared to natural bovine milk. This nutrient-rich milk is helpful for the geriatric population and babies. Milk from transgenic cows, sheep, or goats contains growth hormone, insulin, and anti-blood clotting factors. In the year 2016, the transgenic animals market revenue which is required by some of the biotech industries is expected to occupy a market value of USD 139.4 billion.

In 1997, as per the World Health Organization globally the improvement in natality rate among the population was the increase in cardiovascular diseases. Moreover in 2015, globally it was marked that approximately 32% of people suffered death. Transgenic Animals Market was also due to the rise in cardiovascular disease, and it has also been noted that 7.4 million people died due to coronary heart diseases and 6.7 million people due to heatstroke. Globally, the cost of production of transgenic animals may project at a market value of USD 20,000 to USD 3,00,000.

The Transgenic Animals Market is estimated to grow at an approximate CAGR of 9.50% from 2020 to 2030

Covid 19 Analysis

COVID had a bad effect on the whole of the world for which people feared to travel to the veterinary hospitals. People did not visit the hospitals even when required. This minimized the diagnosis demand and delay in diagnosis was marked. The treatment of the animals also faced little problems. COVID hindered the demand for animal health management products. The coronavirus has failed to keep the livestock free from being healthy.

Market Dynamics

• Drivers- growth in biotechnology units along with the rise in R and D expenses is said to be the driving force of the Transgenic Animals Market. The use of highly prevalent cardiovascular disease, diabetes, and other relatable disorders with the rise in costs for healthcare sectors and the rising awareness about the growth of transgenic animals steers up the transgenic animal’s market growth.


• Opportunities- being much more aware of the health issues of the pets and the growth in government initiatives along with the innovation and launching of new products steers up the Transgenic Animals Market growth and increases the lucrative opportunities which help propel up the business expansion.


• Challenges- shortage of labor became the most challenging factor. This lessens their capacity to work on health-related issues of the animals. Moreover, COVID too became a challenging factor as it led to disruptions in the supply change process and the change in consumer behavior.


• Cumulative Growth- the rise in market value with high CAGR value has helped in the expansion of the market. Following the growth development factors promote the growth of the transgenic animals market industry.


• Restraints- strict rules of government and the policies so put forward by the FDA act as a restraining factor affecting transgenic animals market growth. The rise in developmental costs and reluctance in accepting transgenic products deteriorates the market size during the market forecast period.

Market Segmentation

• By Type- it has been marked that the transgenic market is distinguished based on product, techniques, applications, some of the model organisms, and end-users. Based on product, the market is classified into OCR gene gun, microinjections, electroporator, and many more. The PCR gene gun is classified again into real-time PCR, some of the digital PCR systems, and many others. Based on the techniques, and as per the transgenic animal’s market trends, the transgenic market is distinguished into the retro-virus-mediated transfer of gene, embryonic stem cell-mediated transfer of gene, microinjection of DNA, and many more. Based on consumables, the transgenic animals market growth is divided into fluorescent probes, culture media, etc. as per the application, and also from the transgenic animal’s market analysis, it has been found that the market is classified into recombinant human proteins, monoclonal antibodies, xenotransplantation and many more. Based on model organisms, the transgenic industry is classified into end-users, whereas the market is divided into the biotechnological industry, some of the research organizations, some of the academic institutes, and many more.


• By Technology- by the use of technology, it has been found that pigs can be used for donating organs for human transplant patients. Recombinant DNA technology was proposed which helped for expressing the desirable qualities which are helpful for growth and development. Some of the models were put forward which allowed manipulation of genes and some of the genetic products. Due to the advancement of technology physiological and molecular genetic analysis was made. Some of the drugs have been discovered which were used in both the pharmaceutical and biopharmaceutical industry. Some of the technological innovations showed that genetic engineering technology was put forward. Some of the functional genes were introduced into the animals which were helpful for biological processes and the systems.

Regional Analysis

It has been found that, based on the region, it has been divided into America, Europe, the Middle East, and some of the African regions. It has been found that the American region is said to be the most dominant region which owes a large area of market growth. Here the people have adopted new technology which has helped the people for treatment of diabetes and cardiovascular disease of transgenic animals. High growth in healthcare expenditure, along with the growth in economic conditions in both market and in the healthcare sector which boosts up the market growth. The European region is said to be the second-largest region holding a large transgenic animals market revenue. Growth in research and developmental activities in the medical sectors, along with the huge rise inpatient population has propelled up the market size. 

The United Kingdom is expected to occupy a major share and is said to be the fourth largest manufacturer. Here biotechnological research and developmental activities have taken place in a wide range. In the region of Asia Pacific, the rise in awareness regarding transgenic animals and the increasing awareness about the healthcare units propels up the market growth. An increase in inpatient disposable income of the Transgenic Animals Market during the market forecast period raises the growth. Some of the emerging countries of India and China have a good biotechnological sector along with the growth in infrastructure activities that have fueled up the market growth. As per the Indian Brand Equity Foundation in the year 2017, the Indian biotech market occupies a 2% market share globally. The biotech industry consists of about 800 companies that occupy a market value of about USD 11.6 billion in the year 2017.

Competitive Landscape

Some of the Transgenic Animals Market players playing in the market are Cyagen Biosciences, Sigma-Aldrich Co., Charles River, Abbott, Creative -Biolabs, TRANSGENIC INC. Ltd, Bio-Rad Laboratories, Sutter Instrument Company, Accumold, and more. The key players involve themselves in various growth development strategies. They build the partnership, merge, collaborate and develop acquisitions. It gives a comprehensive view and enhances the value of transgenic drugs.

Recent Developments

• In 2020, a famous manufacturer Merck Animal Health agreed with Automamaziono VX Inc., discovered a subcutaneous chick development technology. This technology will be used for combining Merck Animal Health’s Innovax vaccines which are used for protection against infectious diseases.


• In 2019, Boehringer Ingelheim put forward the largest biotechnology for the discovery of veterinary vaccines in France. Here demand increased along with the rise in growth in poultry consumption.


• In April 2020, Heska Corporation made a partnership with Scil Animal Care emerge and carried out new veterinary projects.


• In June 2020, Chanelle Pharma Group discovered the Spot-On treatment which protects cats and dogs against some of the parasites.

Report Overview

The Market report summarizes the biotechnological techniques which are so used for transgenic animals market applications. It gives details about the vaccine segment which has been put forward. It gives details about the research studies and the routine vaccination systems. It gives a detailed analysis of the market segmentation as to which the market is divided. As per the market trends, it has been marked about the recent developments during the market forecast period. It also symbolizes the growth factors that have helped in improving the growth of the market. The trends depicted in the forecast indicate that soon this market is going to gain good growth.